Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 2, 2003, Pages 395-400

  Dal Col M L C ^a   Orlandi Pereira, L ^a   Rosa, V P ^a   Calixto, A V ^a   Carobrez, A P ^a   Faria, M S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Anxiety; Elevated plus maze; Fear; Learning; Midazolam

Indexed keywords

MIDAZOLAM; SODIUM CHLORIDE; ANXIOLYTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFECT; EMOTION; EXPLORATORY BEHAVIOR; EXPOSURE; LEARNING; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; MOTOR ACTIVITY; PSYCHOLOGICAL ASPECT; WISTAR RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; EXPLORATORY BEHAVIOR; MALE; MIDAZOLAM; MOTOR ACTIVITY; RATS; RATS, WISTAR;

EID: 1842852803     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)01009-2     Document Type: Article

References (34)

1. Diagnostic and statistical manual of mental disorders. 4th ed. 1994;APA Press, Washington (DC).
2. Bertoglio L.J., Carobrez A.P. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav. Brain Res. 108:2000;197-203.
3. Bertoglio L.J., Carobrez A.P. Prior experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 72:2002;449-455.
4. Cahill L., McGaugh J.L. Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci. 21:1998;294-299.
5. Cardenas F., Lamprea M.R., Morato S. Vibrissal sense is not the main sensory modality in rat exploratory behavior in the elevated plus-maze. Behav. Brain Res. 122:2001;169-174.
6. Chacur C., Raymond R., Hipolide D.C., Giugliano E.B., Leite J.R., Nobrega J.N. Immediate increase in benzodiazepine binding in rat brain after a single brief experience in the plus maze: a paradoxical effect. Neurosci. Lett. 269:1999;29-32.
7. Cole J.C., Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav. Pharmacol. 4:1993;573-580.
8. Cruz A.P., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
9. Dawson D.R., Crawford S.P., Stanhope J.K., Iversen S.D., Tricklebank M.D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology. 113:1994;570-572.
10. Duncan G.E., Knapp D.J., Breese G.R. Neuroanatomical characterization of Fos induction in rat behavioral models of anxiety. Brain Res. 713:1996;79-91.
11. Espejo E.F. Effects of weekly or daily exposure to the elevated plus-maze in male mice. Behav. Brain Res. 87:1997;233-238.
12. Fendt M., Fanselow M.S. The neuroanatomical and neurochemical basis of conditioned fear. Neurosci. Biobehav. Rev. 23:1999;743-760.
13. Fernandes C., File S.E. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1996;21-30.
14. File S.E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology. 100:1990;281-282.
15. File S.E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:1993;199-202.
16. File S.E., Zangrossi J.R.H. "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology. 10:1993;240-244.
17. File S.E., Zangrossi J.R.H., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze: a different form of fear? Psychopharmacology. 111:1993;491-494.
18. File S.E., Zangrossi J.R.H., Sanders F.L., Mabbutt P.S. Raised corticosterone in the rat after exposure to the elevated plus-maze. Psychopharmacology. 113:1994;543-546.
19. File S.E., Gonzalez L.E., Gallant R. Role of the basolateral nucleus of the amygdala in the formation of a phobia. Neuropsychopharmacology. 19:1998;397-405.
20. File S.E., Gonzalez L.E., Gallant R. Role of the dorsomedial hypothalamus in mediating the response to benzodiazepines on trial 2 in the elevated plus-maze test of anxiety. Neuropsychopharmacology. 21:1999;312-320.
21. Frussa-Filho R., Ribeiro R.A. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure. Life Sci. 71:2002;519-525.
22. Gonzales L.E., File S.E. A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus. J. Neurosci. 17:1997;1505-1511.
23. Handley S.L., Mithani S. Effects of α2-adrenoceptor agonists and antagonists in a maze exploration model of fear-motivated behaviour. N. S. Arch. Pharmacol. 327:1984;1-5.
24. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54:1996;21-30.
25. Holmes A., Rodgers R.J. Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state? Pharmacol. Biochem. Behav. 60:1998;473-488.
26. Holmes A., Rodgers R.J. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze. Neurosci. Biobehav. Rev. 23:1999;971-980.
27. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
28. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods. 14:1985;149-167.
29. Rodgers R.J., Cole J.C. The elevated plus-maze: pharmacology, methodology and ethology. Cooper S.J., Hendrie C.A. Ethology and psychopharmacology. 1994;9-44 Wiley, Chichester.
30. Rodgers R.J., Shepherd J.K. Influence of prior maze experience on behavior and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice. Psychopharmacology. 113:1993;237-242.
31. Rodgers R.J., Johnson N.J.T., Cole J.C., Dewar C.V., Kidd G.R., Kimpson P.H. Plus-maze retest profile in mice: importance of initial stages of Trial 1 and response to post-trial cholinergic receptor blockade. Pharmacol. Biochem. Behav. 54:1996;41-50.
32. Rosa V.P., Vandresen N., Calixto A.V., Kovaleski D.F., Faria M.S. Temporal analysis of the rat's behaviour in the plus-maze: effect of midazolam. Pharmacol. Biochem. Behav. 67:2000;177-182.
33. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:1993;463-469.
34. Wallace D.G., Gorny B., Whishaw I.Q. Rats can track odors, other rats, and themselves: implications for the study of spatial behavior. Behav. Brain Res. 131:2002;185-192.